AstraZeneca
AZ and Mitsubishi partner on diabetic nephropathy
August 20, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, Mitsubishi, cvmd, diabetes, nephropathy
AstraZeneca and Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) have signed a new three-year research deal in the area of …
Reprieve for AstraZeneca as US drops drug investigation
August 19, 2014Sales and Marketing AstraZeneca, Brilinta, US, blood, justice, plato
The US Justice Department has pulled a controversial investigation into AstraZeneca’s pivotal clinical trial after finding no wrongdoing. The inquiry …
AbbVie/Shire deal under threat from tax laws
August 7, 2014Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion
The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …
AstraZeneca’s second quarter beats estimates
July 31, 2014Research and Development, Sales and Marketing AstraZeneca, Nexium, Pfizer
AstraZeneca posted a set of healthy financial results today as key platforms performed well for the company. Revenue in the …
AstraZeneca secures respiratory drugs from Almirall
July 30, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs
AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …
More action needed on antibiotic resistance
July 25, 2014Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …
MedImmune to work with biotech Advaxis on cancer
July 22, 2014Research and Development, Sales and Marketing Advaxis, AstraZeneca, Cancer, MEDI4736, MedImmune, oncology, pd1
AZ’s MedImmune has entered into a clinical trial collaboration with US biotech firm Advaxis to help develop new cancer immunotherapies. …
Pharma firms give researchers access
July 22, 2014Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library
UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …
AstraZeneca reveals Cambridge plans
July 21, 2014Research and Development, Sales and Marketing AstraZeneca, Cambridge, cbc, research, silicon fen
AstraZeneca’s new international HQ on the Cambridge Biomedical Campus (CBC), due to open in two years’ time, will feature an …
FDA rejects olaparib
June 27, 2014Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib
AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …
AstraZeneca faces olaparib questions
June 24, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, FDA, olaparib, ovarian
AstraZeneca is facing questions from US regulators over the efficacy of one of its most promising late-stage treatments. Olaparib is …
AbbVie moves in on Shire with $46 billion bid
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger
AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …
Genome-driven lung cancer trial launches
June 18, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer
Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …
AstraZeneca signs $240m asthma deal with UK biotech
June 12, 2014Sales and Marketing AZ, AstraZeneca, COPD, SNG001, Synairgen
UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …
MediCity hub moves forward
June 11, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BioCity, alderley park, johnson, medcity, medicity
Nine new businesses have signed tenancy agreements at Nottingham’s MediCity, bringing to 20 the number of companies which have been …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
